Vivent Health has grown to become the second-largest provider of HIV prevention, care, and treatment services in the nation.

The Trump administration is weighing cuts to eliminate the CDC's Division of HIV Prevention, which could impact thousands of ...

“My budget will ask Democrats and Republicans to make the needed commitment to eliminate the HIV epidemic in the United States within 10 years.” The CDC spends about $1 billion a year on ...

After the US slashed global aid, the South African government stated that only 17% of its HIV spending relied on US funding. But some experts argue that US health initiatives had more bang for buck ...

With three noteworthy events, this is a big week for HIV criminalization.What’s more, it kicks off a milestone year for CHLP (the Center for HIV Law and Policy), which celebrates 20 years of fighting ...

Is There a Risk of Miscarriage With HIV? Although women with HIV can indeed have a successful pregnancy and deliver a healthy baby who is not infected with HIV, research does show an increased risk of ...

Among others, a USAID-funded project that helped to keep orphaned children on their HIV medication was forced to close ... In late-January, all of these services were immediately halted following an ...

Why: The stock's decline follows a report from The Wall Street Journal that the US Health and Human Services Department is considering drastic cuts to federal funding for HIV prevention in the US.

£5 allows us to reach millions of people globally with accurate and reliable resources ... the trustees set about ensuring a longevity for the assets aidsmap had built up over four decades. HIV Lens ...

SAN FRANCISCO — Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, baseline suppressive therapies among adults with HIV.

The World Health Organization chief called Monday on Washington to “reconsider” its sharp cuts to aid going towards global ...

It is a novel, first-in-class, long-acting multistage HIV-1 capsid inhibitor currently being developed for PrEP. The study took place at two clinical research centres in the USA. Samples were ...